Not logged in
  Home   Markets   Shares   Funds   Portfolio   Toolbox   Charting   Alerts   Directory   
 Admin   

Tue 27 May 2008, 15:00 ENL - Enaleni Pharmaceuticals Limited - Dealing In Securities By Directors
ENL
ENL                                                                             
ENL - Enaleni Pharmaceuticals Limited - Dealing In Securities By Directors      
Enaleni Pharmaceuticals Limited                                                 
(Incorporated in the Republic of South Africa)                                  
(Registration number 2002/018027/06)                                            
(JSE code: ENL & ISIN: ZAE000067740)                                            
("Enaleni")                                                                     
DEALING IN SECURITIES BY DIRECTORS                                              
In terms of paragraph 3.63 - 3.65 of the JSE Limited Listings Requirements, the 
following information relates to the dealing in securities by directors of      
Enaleni and its major subsidiary:                                               
Executive director:                JS Smith                                     
Company:                           Enaleni Pharmaceuticals Limited              
Number of shares:                  1 919 765                                    
Strike price:                      296 cents per share                          
Value of transaction:              R5 682 504.40                                
Extent of interest:                Direct beneficial                            
Date of transaction:               26 May 2008                                  
Nature of transaction:             Grant and acceptance of share options in     
                                  terms of the Enaleni Share Incentive Trust    

Written clearance to deal obtained:     Yes                                     
Executive director:                C Aucamp                                     
Company:                           Enaleni Pharmaceuticals Limited              
Number of shares:                  602 999                                      
Strike price:                      296 cents per share                          
Value of transaction:              R1 784 877.04                                
Extent of interest:                Direct beneficial                            
Date of transaction:               26 May 2008                                  
Nature of transaction:             Grant and acceptance of share options in     
                                  terms of the Enaleni Share Incentive          
                                       Trust                                    
Written clearance to deal obtained:     Yes                                     
Executive director:                AD Watermeyer                                
Company:                           Cipla Medpro Holdings (Proprietary)          
                                  Limited                                       
Number of shares:                  405 078                                      
Strike price:                      296 cents per share                          
Value of transaction:              R1 199 030.88                                
Extent of interest:                Direct beneficial                            
Date of transaction:               26 May 2008                                  
Nature of transaction:             Grant and acceptance of share options in     
                                  terms of the Enaleni Share Incentive Trust    
Written clearance to deal obtained:     Yes                                     
Durban                                                                          
27 May 2008                                                                     
Sponsor                                                                         
Nedbank Capital                                                                 
Date: 27/05/2008 15:00:01 Produced by the JSE SENS Department.                  
The SENS service is an information dissemination service administered by the    
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or            
implicitly, represent, warrant or in any way guarantee the truth, accuracy or   
completeness of the information published on SENS. The JSE, their officers,     
employees and agents accept no liability for (or in respect of) any direct,     
indirect, incidental or consequential loss or damage of any kind or nature,     
howsoever arising, from the use of SENS or the use of, or reliance on,          
information disseminated through SENS.
Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information.
Other Profile Group sites: FundsData Online (unit trust data)  |  Profile Group corporate site
[  Terms of Use |  Privacy Policy |  PAIA manual |  FAQs/Help |  Site Map |  © Copyright Reserved 2026  ]
  


Powered by ProfileData

Profile Mobile App Google Play Store Apple App Store


Follow us on: